logo

4.045

4.04 (-1.77%)

As of Mar 06, 2024

Genenta Science S.P.A. [GNTA]

Source: 

Company Overview

Genenta Science S.p.a is a clinical-stage biotechnology company engaged in the development of hematopoietic stem cell gene therapies for the treatment ofsolid tumors. We have developed a novel biologic platform that involves the ex-vivo gene transfer of a therapeutic candidate intoautologous hematopoietic stem/progenitor cells (“HSPCs”) to deliver immunomodulatory molecules directly to the tumor by infiltratingmonocytes/macrophages.

CountryItaly
Headquartersmilan
Phone Number39-02-2643-6639
Industry
CEOPierluigi Paracchi
Websitegenenta.com